Matinas BioPharma Holdings, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Matinas BioPharma Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Matinas BioPharma Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 5.09M shares, a 97.7% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.09M -212M -97.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 251M +33.6M +15.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 217M +218K +0.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.35M -213M -98% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 217M +400K +0.18% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 217M +400K +0.18% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 217M +400K +0.18% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 217M +995K +0.46% Dec 31, 2022 10-K 2024-03-27
Q3 2022 217M +617K +0.29% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 217M +2.24M +1.04% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 217M +12.6M +6.16% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 216M +16.2M +8.07% Dec 31, 2021 10-K 2023-03-15
Q3 2021 216M +17.3M +8.68% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 215M +15.8M +7.92% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 204M +7.08M +3.59% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 200M +37M +22.7% Dec 31, 2020 10-K/A 2022-03-11
Q3 2020 199M +36.2M +22.3% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 199M +54.7M +37.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 197M +54.2M +37.9% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 163M +49.9M +44% Dec 31, 2019 10-K 2021-03-29
Q3 2019 163M +65M +66.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 144M +50M +53% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 143M +49M +52.1% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 113M +19.9M +21.3% Dec 31, 2018 10-K 2020-03-09
Q3 2018 97.7M +4.75M +5.11% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 94.2M +2.26M +2.46% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 94M +3M +3.29% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 93.4M +35.2M +60.5% Dec 31, 2017 10-K 2019-04-01
Q3 2017 93M +35M +60.5% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 92M +34.4M +59.7% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 91M +33.4M +58% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 58.2M +979K +1.71% Dec 31, 2016 10-K 2018-03-16
Q3 2016 57.9M +712K +1.25% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 57.6M +626K +1.1% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 57.6M +10.8M +23.1% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 57.2M +24.9M +77.1% Dec 31, 2015 10-K 2017-03-31
Q3 2015 57.2M +25M +77.8% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 57M +25M +78% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 46.8M +14.8M +46.2% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 32.3M +293K +0.92% Dec 31, 2014 10-K 2016-03-30
Q3 2014 32.2M Sep 30, 2014 10-Q 2014-11-14
Q2 2014 32M Jun 30, 2014 10-Q 2014-08-08
Q1 2014 32M Mar 31, 2014 10-Q/A 2014-06-06
Q4 2013 32M Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.